# EDGAR Filing Document

**Accession Number:** 0000879911
**File Stem:** 0001213900-26-004106
**Filing Date:** 2026-1
**Character Count:** 42223
**Document Hash:** 11e76cd17476cdcb083a2c42b4edcf60
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-004106.hdr.sgml**: 20260114

**ACCESSION NUMBER**: 0001213900-26-004106

**CONFORMED SUBMISSION TYPE**: 424B3

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260114

**DATE AS OF CHANGE**: 20260113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** APPLIED ENERGETICS, INC.
- **CENTRAL INDEX KEY:** 0000879911
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEARCH, DETECTION, NAVIGATION, GUIDANCE, AERONAUTICAL SYS [3812]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 770262908
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 424B3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-292156
- **FILM NUMBER:** 26531276

**BUSINESS ADDRESS:**
- **STREET 1:** 9070 S. RITA ROAD
- **STREET 2:** SUITE 1500
- **CITY:** TUCSON
- **STATE:** AZ
- **ZIP:** 85747
- **BUSINESS PHONE:** 520-628-7415

**MAIL ADDRESS:**
- **STREET 1:** 9070 S. RITA ROAD
- **STREET 2:** SUITE 1500
- **CITY:** TUCSON
- **STATE:** AZ
- **ZIP:** 85747

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IONATRON, INC.
- **DATE OF NAME CHANGE:** 20040429

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** US HOME & GARDEN INC
- **DATE OF NAME CHANGE:** 19950714

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NATURAL EARTH TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19930328

**Filed Pursuant to Rule 424(b)(3)<br> Registration No. 333-292156**

**PROSPECTUS**

**APPLIED ENERGETICS, INC.**

**11,391,064 Shares of Common Stock**

This prospectus relates to the resale of up to an aggregate of 11,391,064 outstanding shares of common stock, par value $0.001 per share, of Applied Energetics, Inc. to be sold by selling stockholders named herein (whom we refer to as the "Selling Stockholders"). Each of the Selling Stockholders purchased the shares in a private transaction as described herein.

The Selling Stockholders are offering their shares at varying prices, at different times and in different ways. Information on the Selling Stockholders and the times and manner in which they may offer and sell shares of our common stock under this prospectus is provided under "Selling Stockholders" and "Plan of Distribution." We are not offering any shares under this prospectus nor will Applied Energetics receive any of the proceeds from this offering. We expect to pay for expenses associated with the registration and offering of the shares under this prospectus.

Our common stock is quoted on the OTCQB under the ticker symbol "AERG." On December 10, 2025, the closing price of our common stock was $1.90 per share. We have made an application to The Nasdaq Stock Market to list our common stock on The Nasdaq Capital Market, although there can be no assurance that our application will be approved.

**Investing in our securities is speculative and involves a high degree of risk. You should review carefully the risks and uncertainties referred to under the heading "Risk Factors" contained in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the documents that are incorporated by reference into this prospectus as described on page 12 of this prospectus.**

**Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.**

**The date of this prospectus is December 23, 2025.**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| [ABOUT THE PROSPECTUS](#a_001) | 1 |
| [CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION](#d_006) | 2 |
| [ABOUT APPLIED ENERGETICS, INC.](#a_007) | 3 |
| [RISK FACTORS](#a_004) | 5 |
| [USE OF PROCEEDS](#a_005) | 6 |
| [SELLING STOCKHOLDERS](#a_008) | 7 |
| [PLAN OF DISTRIBUTION](#a_009) | 9 |
| [DESCRIPTION OF SECURITIES TO BE REGISTERED](#a_010) | 11 |
| [LEGAL MATTERS](#a_011) | 11 |
| [EXPERTS](#a_012) | 11 |
| [WHERE YOU CAN FIND MORE INFORMATION](#d_004) | 12 |
| [INCORPORATION OF CERTAIN INFORMATION BY REFERENCE](#d_005) | 12 |

---

i

**ABOUT THE PROSPECTUS**

This prospectus is part of a "shelf" registration statement that we filed with the Securities and Exchange Commission (the "SEC"). By using a shelf registration statement, the Selling Stockholders identified in this prospectus may sell an aggregate of up to 11,391,064 shares of our common stock from time to time in one or more offerings, as described in this prospectus. We will not receive any proceeds from such sales by the Selling Stockholders.

Neither we nor the Selling Stockholders have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Stockholders take responsibility for and can provide no assurance as to the reliability of, any other information that others may give you. The Selling Stockholders will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted.

We may also provide a prospectus supplement or post-effective amendment to this registration statement to add information to, or update or change information contained in, this prospectus. You should read both this prospectus and any applicable prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer you in the sections of this prospectus entitled "Where You Can Find More Information" and "Incorporation of Certain Information by Reference."

For investors outside the United States: We have done nothing that would permit this offering or possession or distribution of this prospectus or any free writing prospectus we may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus and any such free writing prospectus outside of the United States.

This prospectus is neither an offer to sell, nor a solicitation of an offer to buy, these securities in any jurisdiction where an offer or solicitation would be unlawful. Unless otherwise indicated or the context otherwise requires, all references in this prospectus to "we," "us," the "Company," "AE," and "AERG" mean Applied Energetics, Inc.

**CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS**

This prospectus contains certain statements relating to our future results that are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some of these statements can be identified by use of forward-looking words such as "believes," "expects," "anticipates," "may," "should," "seeks," "approximately," "intends," "plans" or "estimates," or the negative of these words, or other comparable terminology. The discussion of financial trends, strategy, plans or intentions may also include forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties, including, but not limited to, changes in political and economic conditions; interest rate fluctuation; competitive pricing pressures within our market; equity and fixed income market fluctuation; technological change; changes in law; changes in fiscal, monetary regulatory and tax policies as well as other risks and uncertainties detailed elsewhere in this prospectus or from time-to-time in our filings with the SEC. Such forward-looking statements speak only as of the date on which such statements are made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

You should not consider the above list to be a complete statement of all risks and uncertainties. You are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by federal securities laws, we undertake no obligation to publicly release the result of any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

**ABOUT APPLIED ENERGETICS, INC.**

**Overview**

Applied Energetics, Inc. specializes in advanced laser and photonics systems, particularly fiber-based ultrashort pulse (USP) laser technologies. With 28 patents and 5 patents pending, Applied Energetics' proprietary architecture enables orders of magnitude size-weight-power reductions, a key differentiator when compared with traditional continuous wave (CW) laser technology with larger footprints. AE's powerful, dual-use systems are designed for integration and deployment on numerous potential defense platforms for the delivery of high intensity, USPs of light to disable or destroy a target or disrupt a mission. These technologies have applications in both national security and commercial markets. Today, AE's USP optical technologies are being designed to offer flexibility and power for complex missions in national security such as enhancing layered defense strategies to counter complex threats.

**Technology, Capabilities, and Patents**

Applied Energetics, Inc. is as a leader in developing the next generation optical sources exhibiting ever-increasing output energy, peak power and frequency agility while also providing decreased size, weight, and cost of these systems for customers. Applied Energetics utilizes patented, dual-use technologies to advance critical industries. Leveraging our proprietary fiber-based architecture and wavelength- and pulse-agility capability, our USP technology can enable users to achieve specific effects across different use cases with an unmatched blend of size, weight, and power attributes. While initially designed to meet the emerging needs and priorities for the national security community, our directed energy technology also has commercial applications in both the biomedical and advanced manufacturing industries.

Our USP Lasers are designed to provide:

● Frequency Agile Optical Sources from Ultraviolet (UV) to Far Infrared (IR)

● Pulse Duration Agility

● Size, Weight, and Power Optimization

● Advanced Fiber Applications

● Laser Guided Energy (LGE®)

● Laser Induced Plasma Channel (LIPC®)

Applied Energetics' directed energy technologies are vastly different from conventional directed energy systems, i.e., Applied Energetics' proprietary fiber-based architecture is a key differentiator for our most recent technology demonstrators. Compared with traditional continuous wave laser technologies, with their larger footprints, AE's architecture enables orders of magnitude size-weight-power reductions on all deliverables, creating powerful, dual-use and agile systems that can fit a host of platforms while delivering very high-intensity, ultrashort pulses of light to the required target. This directed energy solution allows extremely high peak power and energy, with target and effects tunability, and is effective against a wide variety of potential targets.

Applied Energetics' optical fiber-based laser architectures also enable unmatched wavelength agility as well as pulse duration agility. Using innovative and highly specialized frequency shifting techniques, wavelengths can be custom tuned from the deep ultraviolet to the far infrared. In addition, temporal outputs can be adjusted from continuous wave to sub-picoseconds. The technology enables the customer to adjust the lasers' operating parameters, ultimately creating more flexibility to change wavelength and pulse width. This feature allows for optimization of laser performance for defense or commercial applications.

Our proprietary USP laser technology provides a significantly more compact solution than current continuous wave laser platforms while still delivering high peak power. Continuous wave laser systems are typically used to heat a target and, during continuous illumination, this heat transfer leads to melting or charring of the material. Using continuous wave output powers that now exceed 100 kilowatts (1kW = 1000 watts), it can take anywhere from seconds to minutes to impact a target. By contrast, Applied Energetics has delivered USP lasers to national security users that exceed five terawatts (1 TW = 1 trillion watts) in peak power, with the difference being that this peak power from a USP laser is delivered in a pulse that is less than a trillionth of a second. During this short pulse duration, and having such a high peak intensity, near-instantaneous ablation of the surface of the threat takes place. The net result of our innovative USP approaches is highly effective lasers capable of jamming, damaging, and destroying certain surveillance and reconnaissance sensors with mountable footprints that require only a fraction of the size, weight, and power requirements of other-directed energy technologies. We believe the combination of both low size, weight, and power characteristics with wavelength and pulse duration agility will help us achieve our vision statement of Directed Energy, Anywhere.

The Applied Energetics scientific team is continuously innovating with an eye toward expanding our patent portfolio to cover these technological breakthroughs and further enhance our suite of solutions for threat disruption for the Department of Defense, the intelligence community, and for commercial, biomedical and space applications with optical sources operating from the deep ultraviolet to the far infrared portions of the electromagnetic spectrum.

Applied Energetics has developed, successfully demonstrated, and holds all crucial intellectual property rights to a dynamic directed energy technology called Laser Guided Energy (LGE®) and Laser Induced Plasma Channel (LIPC®). LGE and LIPC are technologies that can be used in a new generation of high-tech directed energy systems. Applied Energetics' LGE and LIPC technologies are wholly owned by Applied Energetics and protected by one or more of Applied Energetics' 28 issued patents and 9 Government Sensitive Patent Applications (GSPA). These GSPA's are held under secrecy orders of the US government, providing the Company with extended protection rights.

More recently, the Company has been awarded a new patent for application in the national security domain (Pulsed Laser Thermal Excitation, Patent No.: US 12,171,055 B2) and received notice of an allowed patent application in the healthcare domain (Pathogen Detection and Neutralization Using Deep UV-C Generation Via Seeded Raman Amplification and Second Harmonic Generation, Patent Application No.: US 2023/01804590 A1). The Company also has five pending patent applications. We continue to file patent applications as we deem appropriate to protect our intellectual property and enhance our competitive advantage.

As Applied Energetics looks toward the future, our corporate strategic roadmap builds upon the significant value of the Company's USP laser capabilities and key intellectual property, including LGE and LIPC, to offer our prospective partners, co-developers and system integrators a variety of next-generation ultrashort pulse and frequency-agile optical sources, from the ultraviolet to the far infrared portion of the electromagnetic spectrum, to address numerous challenges within the national security, biomedical, and advanced manufacturing market sectors.

**Corporate Information**

Applied Energetics, Inc. is a corporation organized and existing under the laws of the State of Delaware. Our executive office is located at 9070 S. Rita Road, Suite 1500, Tucson, Arizona 85747 and our telephone number is (520) 628-7415.

**RISK FACTORS**

Investing in our securities involves a high degree of risk. Before making a decision to invest in our securities, in addition to the other information contained in this prospectus, any accompanying prospectus supplement or any related free writing prospectus, or incorporated by reference herein or therein, you should carefully consider the risks discussed under "Risk Factors" in our most recent Annual Report on Form 10-K, in any prospectus supplement related hereto, and in other information contained in our publicly available SEC filings and press releases. See "Where You Can Find More Information."

**USE OF PROCEEDS**

We will not receive any of the proceeds from the sale of common stock being offered by the Selling Stockholders.

We will pay for the expenses of this offering, except that the Selling Stockholders will pay any broker discounts or commissions or equivalent expenses and expenses of Selling Stockholder legal counsel, if any, applicable to any sale of the shares.

**SELLING STOCKHOLDERS**

The following table sets forth the information as to the ownership of our securities by the Selling Stockholders on December 9, 2025, at which time 223,608,831 shares of our common stock were outstanding. Unless otherwise indicated, it is assumed that each Selling Stockholder listed below possesses sole voting and investment power with respect to the shares owned as of such date by the Selling Stockholder.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Selling Stockholder (1)** | **Shares of<br> Common<br> Stock<br> Owned<br> Before the<br> Offering** | **Percentage of<br> Comon Stock Beneficially Owned Before the Offering** | **Maximum Number of<br> Shares of<br> Common<br> Stock to be<br> Offered (1) (2)** | **Shares of<br> Common<br> Stock to be<br> Beneficially<br> Owned<br> After the<br> Offering (1)** | **Percentage of<br> Common<br> Stock<br> Beneficially<br> Owned<br> After the<br> Offering** |
| Bryon Adamczyk | 66667 | \* | 66667 | -0- |  |
| Stephen Baksa | 11158080<sup>(3)</sup> | 4.99% | 2179819 | 9624912 | 4.31% |
| Alvina Balog Trust fbo Stephen J Balog | 266667 | \* | 266667 | -0- |  |
| Edward M Giles Revocable Trust(4) | 1898403<sup>(4)</sup> | \*<sup>(3)</sup> | 1100666<sup>(3)</sup> | 797737 |  |
| Everglades Global Opportunities Fund LP | 188888 | \* | 188888 | -0- |  |
| Eric N. Fein | 38888 |  | 38888 | -0- |  |
| Isles Capital, L.P. | 2078874<sup>(5)</sup> | \* | 114000 | 1615000 | \* |
| Joseph Mannello | 335555 | \* | 55555 | 280000 | \* |
| John Moss | 300675 | \* | 300000 | 675 | \* |
| Frank Pollaro | 592000 | \* | 592000 | -0- |  |
| Richard Pringle | 93333 | \* | 93333 | -0- |  |
| Red Cedar Onshore Fund | 11158080<sup>(6)</sup> | 4.99% | 4236501<sup>(5)</sup> | 9832598 | 4.71 |
| Stephen J. Schaefer | 523331<sup>(7)</sup> | \* | 100000 | 423331 | \* |
| Robert Michael Schilling III | 830000 | \* | 200000 | 630000 | \* |
| Dylan Stuart | 133333 | \* | 133333 | -0- |  |
| Superius Securities Group Inc Profit Sharing Plan | 9016827 |  | 1111111 | 7905716 | 3.5% |
| The Cory and Angela Tribble Family Trust, U/A/D November 8, 2021 | 138036 | \* | 113636 | -0- |  |
| David Verlander | 1803000 | \* | 500000 | 1303000 | \* |
| **TOTAL** |  |  | 11391064 |  |  |

---

● Less than 1%.

(1) Assumes
 all of the shares being offered under this Prospectus will be sold by the Selling Stockholders.
 However, we are unable to determine the exact number of shares, if any, that will actually
 be sold hereunder.

(2) Represents
 the shares held by the Selling Stockholders which we have agreed to include in this Prospectus.

(3) Includes
 shares underlying warrants in the amount of 2,179,819, the exercise of which is subject to
 a beneficial ownership limitation.

(4) Edward
 M Giles Revocable Trust is controlled by Edward M. Giles who also beneficially holds, himself,
 through his spouse, and through one or more entities, an additional 4,532,139 shares.

(5) Walter
 K. Giles is the General Partner of Isles Capital. Mr. Giles also beneficially holds, himself,
 as trustee of one or more family trusts, or jointly with his wife, an additional 1,717,719.

(6) Includes
 shares underlying warrants in the amount of 3,781,955, the exercise of which is subject to
 a beneficial ownership limitation.

(7) Includes
 79,504 shares owned by Mr. Schaefer's spouse and an additional 1,169 shares held by
 them jointly.

The information set forth above is based upon information obtained from the Selling Stockholders and upon information in our possession regarding the issuance of shares of common stock and warrants to the Selling Stockholders in connection with private placement transactions. None of the Selling Stockholders has within the past three years had any position, office or other material relationship with us or any of our subsidiaries other than as a holder of shares of our common stock or warrants.

**Transactions with Selling Stockholders**

Each of the Selling Stockholders listed above purchased the shares registered for possible resale in one or more of the following transactions:

On May 10, 2024, the Company completed the placement of 1,896,182 shares of its common stock, par value, $0.001 per share, in a private sale to individual purchasers at a price of $2.20 per share, for aggregate proceeds in the amount of $4,171,600.

On January 14, 2025, the Company completed the placement of 6,405,666 shares of its common stock, par value, $0.001 per share, some of which were underlying pre-funded common stock purchase warrants, in a private sale to individual purchasers at a price of $0.75 per share (or $0.749 per underlying share for pre-funded warrants), for aggregate proceeds in the approximate amount of $4,804,249. The pre-funded warrants are exercisable immediately at a price of $0.001 per share but may not be executed in any amount which would cause the holder thereof to beneficially own 5% or more of the Company's common stock.

On February 6, 2025, the Company completed the placement of 1,600,000 shares of its common stock, par value, $0.001 per share, some of which were underlying pre-funded common stock purchase warrants, in a private sale to individual purchasers at a price of $0.75 per share (or $0.749 per underlying share for pre-funded warrants), for aggregate proceeds in the amount of $1,200,000. The pre-funded warrants are exercisable immediately at a price of $0.001 per share but may not be executed in any amount which would cause the holder thereof to beneficially own 5% or more of the Company's common stock. The Company has agreed to use its best efforts to include the shares for registration with the SEC in the registration statement it files.

On October 8, 2025, the Company completed the placement of 5,995,675 shares of its common stock, par value, $0.001 per share, some of which were underlying pre-funded common stock purchase warrants, in a private sale to individual purchasers at a price of $1.80 per share (or $1.799 per underlying share for pre-funded warrants), for aggregate proceeds in the amount of $10,789,999. The pre-funded warrants are exercisable immediately at a price of $0.001 per share but may not be executed in any amount which would cause the holder thereof to beneficially own in excess of 4.99% of the Company's common stock. The Company has agreed to use its best efforts to include the shares for registration with the SEC in the registration statement it files.

All of the purchasers in the foregoing transactions were accredited, sophisticated investors, and the issuance of the shares was not in connection with any public offering in accordance with Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). Each of the Selling Stockholders participated in one or more of the aforesaid offerings.

**PLAN OF DISTRIBUTION**

Each Selling Stockholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the OTCQB or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:

● ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

● block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;

● purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

● an exchange distribution in accordance with the rules of the applicable exchange;

● privately negotiated transactions;

● settlement of short sales entered into after the effective date of the registration statement of which this prospectus is a part;

● in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;

● through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

● a combination of any such methods of sale; or

● any other method permitted pursuant to applicable law.

The Selling Stockholders may also sell securities under Rule 144 under the Securities Act, if available, rather than under this prospectus.

Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction, not in excess of a customary brokerage commission in compliance with FINRA Rule 2440; and in the case of a principal transaction a markup or markdown in compliance with FINRA IM-2440.

In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

We will pay all of the expenses incident to the registration, offering, and sale of the shares to the public other than commissions or discounts of underwriters, broker-dealers, or agents. Any commissions, discounts or other fees payable to brokers-dealers in connection with any sale of the shares of common stock will be borne by the selling stockholders, the purchasers participating in such transaction, or both.

The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be "underwriters" within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. We know of no existing arrangements between the selling stockholders, any other shareholder, broker, dealer, underwriter, or agent relating to the sale or distribution of the shares offered by this prospectus. In no event shall any broker-dealer receive fees, commissions and markups which, in the aggregate, would exceed eight percent (8%).

Because Selling Stockholders may be deemed to be "underwriters" within the meaning of the Securities Act, they will be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder. In addition, any securities covered by this Prospectus which qualify for sale pursuant to Rule 144 under the Securities Act may be sold under Rule 144 rather than under this Prospectus.

We agreed to keep this Prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

**Under applicable rules and regulations under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), any person engaged in the distribution of the resale shares may not simultaneously engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of shares of the common stock by the Selling Stockholders or any other person. We will make copies of this Prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this Prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).** 

**Penny Stock Rules**

Our shares of common stock are subject to the "penny stock" rules of the Exchange Act. In general terms, "penny stock" is defined as any equity security that has a market price less than $5.00 per share, subject to certain exceptions. The rules provide that any equity security is considered to be a penny stock unless that security is registered and traded on a national securities exchange meeting specified criteria set by the SEC, authorized for quotation from the NASDAQ stock market, issued by a registered investment company, and excluded from the definition on the basis of price (at least $5.00 per share), or based on the issuer's net tangible assets or revenues. In the last case, the issuer's net tangible assets must exceed $3,000,000 if in continuous operation for at least three years or $5,000,000 if in operation for less than three years, or the issuer's average revenues for each of the past three years must exceed $6,000,000.

Trading in shares of penny stock is subject to additional sales practice requirements for broker-dealers who sell penny stocks to persons other than established customers and accredited investors. Accredited investors, in general, include individuals with assets in excess of $1,000,000 or annual income exceeding $200,000 (or $300,000 together with their spouse), and certain institutional investors. For transactions covered by these rules, broker-dealers must make a special suitability determination for the purchase of the security and must have received the purchaser's written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, the rules require the delivery, prior to the first transaction, of a risk disclosure document relating to the penny stock. A broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, and current quotations for the security. Finally, monthly statements must be sent disclosing recent price information for the penny stocks. These rules may restrict the ability of broker-dealers to trade or maintain a market in our common stock, to the extent it is penny stock, and may affect the ability of stockholders to sell their shares.

**DESCRIPTION OF SECURITIES TO BE REGISTERED**

The following description of our capital stock being registered herein is a summary only and is qualified in its entirety by reference to our Articles of Incorporation, as amended, and Amended and Restated Bylaws, which are included as Exhibits 3.1 through 3.7 of the Company's Annual Report on Form 10-K (incorporating such documents by reference to prior reports on file with the SEC by the Company).

**Common Stock**

We are authorized to issue up to 500,000,000 shares of common stock, $0.001 par value per share. The holders of our common stock are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders and do not have cumulative voting rights. Subject to preferences that may be applicable to any outstanding shares of preferred stock, the holders of our common stock are entitled to receive ratably such dividends as may be declared by our board of directors out of legally available funds. Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any then outstanding shares of preferred stock. Our common stock does not carry any preemptive rights enabling a holder to subscribe for, or receive shares of, any class of our common stock or any other securities convertible into shares of any class of our common stock, or any redemption rights.

Our common stock is quoted on the OTCQB under the ticker symbol "AERG." We have made an application to The Nasdaq Stock Market to list our common stock on The Nasdaq Capital Market, although there can be no assurance that our application will be approved.

**Transfer Agent and Registrar**

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company.

**LEGAL MATTERS**

Unless otherwise stated in an accompanying prospectus supplement, Mary P. O'Hara, the Company's General Counsel and Chief Legal Officer, will provide us with an opinion as to the legality of the securities offered under this prospectus.

**EXPERTS**

The consolidated financial statements of Applied Energetics, Inc. and subsidiary, as of and for the year ended December 31, 2024 and 2023, have been incorporated by reference herein in reliance upon the report of RBSM LLP, independent registered public accounting firm, and upon the authority of said firm as expert in accounting and auditing.

**WHERE YOU CAN FIND MORE INFORMATION**

We file annual, quarterly and current reports, proxy statements, and other information with the SEC. We have filed with the SEC a registration statement on Form S-3 under the Securities Act, with respect to the securities covered by this prospectus. This prospectus, which is a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information with respect to us and the securities covered by this prospectus, please refer to the registration statement, its exhibits and schedules and our reports, proxies and other information filed with the SEC.

Our filings are available to the public on the Internet, through a database maintained by the SEC at *www.sec.gov*. We also maintain a website at *www.appliedenergetics.com*. We have included our website address for the information of prospective investors and do not intend it to be an active link to our website. Information contained on our website does not constitute a part of this prospectus or any applicable prospectus supplement (or any document incorporated by reference herein or therein).

**INCORPORATION OF CERTAIN INFORMATION BY REFERENCE**

The SEC allows us to "incorporate by reference" into this prospectus the information that we file with the SEC. This permits us to disclose important information to you by referring to these filed documents. Any information referred to in this way is considered part of this prospectus, and any information filed with the SEC by us after the date of this prospectus will automatically be deemed to update and supersede this information.

Because we are incorporating by reference future filings with the SEC, this prospectus is continually updated and those future filings may modify or supersede some of the information included or incorporated in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any document previously incorporated by reference have been modified or superseded. This prospectus incorporates by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K or related exhibits furnished pursuant to Item 9.01 of Form 8-K and other documents or portions of documents that are furnished, but not deemed to be filed), including, without limitation, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and proxy statements, between the date of the registration statement and the effectiveness of the registration statement and following the effectiveness of the registration statement until the offering of the securities under the registration statement is terminated or completed, including:

● our Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/879911/000101376225003924/ea0234361-10k_applied.htm) for the year ended December 31, 2024 , filed with the SEC on March 28, 2025;

● our Quarterly Report on Form 10-Q for the quarters ended March 31, June 30, and September 30, 2025 , filed with the SEC on [May 15](https://www.sec.gov/Archives/edgar/data/879911/000121390025043482/ea0241122-10q_applied.htm) , [August 13](https://www.sec.gov/Archives/edgar/data/879911/000121390025075742/ea0252534-10q_applied.htm) , and [November 12, 2025](https://www.sec.gov/Archives/edgar/data/879911/000121390025109366/ea0264527-10q_applied.htm) , respectively;

● our Current Reports on Form 8-K filed with the SEC on [January 15, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025003629/ea0227742-8k_applied.htm) , [February 6, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025010993/ea023026501-8k_applied.htm) , [March 25, 2025](http://www.sec.gov/Archives/edgar/data/879911/000101376225002250/ea023563601-8k_applied.htm) , [June 9, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025052360/ea0245095-8k_applied.htm) , [September 18, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025088705/ea0257742-8k_applied.htm) , [September 25, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025091659/ea0258840-8k_applied.htm) , [September 29, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025093137/ea0259324-8k_applied.htm) , [October 8, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025097394/ea0260676-8k_applied.htm) , [October 9, 2025](http://www.sec.gov/Archives/edgar/data/879911/000121390025097866/ea026087001-8k_applied.htm) ; and

● the description of our common stock set forth in [Exhibit 4.2](http://www.sec.gov/Archives/edgar/data/879911/000121390023024192/f10k2022ex4-2_appliedener.htm) to our Annual Report on [Form 10-K](http://www.sec.gov/Archives/edgar/data/879911/000101376225003924/ea0234361-10k_applied.htm) for the fiscal year ended December 31, 2024.

We also incorporate by reference into this prospectus all documents (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) that are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act until we file a post-effective amendment which indicates the termination of the offering of the securities made by this prospectus.

Documents incorporated by reference are available from us, without charge. You may obtain documents incorporated by reference in this prospectus by requesting them in writing or by telephone at the following address: Applied Energetics, Inc., 9070 S. Rita Road, Suite 1500, Tucson, AZ 85747, Attn.: Warren Spector, Vice President, Finance.

You also may access these filings on our website at *www.appliedenergetics.com*. Our web site and the information contained on that site, or connected to that site, are not incorporated into this prospectus or the registration statement of which this prospectus is a part.

Any statement contained in this prospectus or contained in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded to the extent that a statement contained in this prospectus or in any subsequently filed supplement to this prospectus, or document deemed to be incorporated by reference into this prospectus modifies or supersedes that statement.

**Applied Energetics, Inc.**

![](image_002.jpg)

**11,391,064 Shares of Common Stock**

**Offered by the Selling Stockholders**

**PROSPECTUS**

**The date of this prospectus is December 23, 2025.**